Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status: letter to the editor
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
24 October 2023
|
| In: |
Acta Neuropathologica Communications
Year: 2023, Jahrgang: 11, Pages: 1-4 |
| ISSN: | 2051-5960 |
| DOI: | 10.1186/s40478-023-01667-x |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s40478-023-01667-x Verlag, kostenfrei, Volltext: https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01667-x 
|
| Verfasserangaben: | Arnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, Philipp Sievers, Andreas von Deimling, Felix Sahm, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, Pascale Varlet |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1882343549 | ||
| 003 | DE-627 | ||
| 005 | 20240307021618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40478-023-01667-x |2 doi | |
| 035 | |a (DE-627)1882343549 | ||
| 035 | |a (DE-599)KXP1882343549 | ||
| 035 | |a (OCoLC)1425200386 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Tauziède-Espariat, Arnault |e VerfasserIn |0 (DE-588)1245411365 |0 (DE-627)1776496833 |4 aut | |
| 245 | 1 | 0 | |a Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status |b letter to the editor |c Arnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, Philipp Sievers, Andreas von Deimling, Felix Sahm, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, Pascale Varlet |
| 264 | 1 | |c 24 October 2023 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.03.2024 | ||
| 700 | 1 | |a Uro-Coste, Emmanuelle |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicaise, Yvan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sievers, Philipp |e VerfasserIn |0 (DE-588)1075154790 |0 (DE-627)832941514 |0 (DE-576)443264953 |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Sahm, Felix |d 1984- |e VerfasserIn |0 (DE-588)1022852132 |0 (DE-627)717318478 |0 (DE-576)366075020 |4 aut | |
| 700 | 1 | |a Aboubakr, Oumaima |e VerfasserIn |4 aut | |
| 700 | 1 | |a Métais, Alice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chrétien, Fabrice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Varlet, Pascale |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta Neuropathologica Communications |d London : Biomed Central, 2013 |g 11(2023), Artikel-ID 170, Seite 1-4 |h Online-Ressource |w (DE-627)746066465 |w (DE-600)2715589-4 |w (DE-576)382284372 |x 2051-5960 |7 nnas |a Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status letter to the editor |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g elocationid:170 |g pages:1-4 |g extent:4 |a Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status letter to the editor |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s40478-023-01667-x |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01667-x |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240301 | ||
| 993 | |a Editorial | ||
| 994 | |a 2023 | ||
| 998 | |g 1022852132 |a Sahm, Felix |m 1022852132:Sahm, Felix |d 910000 |d 912000 |d 50000 |e 910000PS1022852132 |e 912000PS1022852132 |e 50000PS1022852132 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 6 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1075154790 |a Sievers, Philipp |m 1075154790:Sievers, Philipp |d 910000 |d 912000 |e 910000PS1075154790 |e 912000PS1075154790 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 999 | |a KXP-PPN1882343549 |e 4494881937 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1882343549"],"doi":["10.1186/s40478-023-01667-x"]},"person":[{"given":"Arnault","family":"Tauziède-Espariat","role":"aut","display":"Tauziède-Espariat, Arnault"},{"display":"Uro-Coste, Emmanuelle","role":"aut","family":"Uro-Coste","given":"Emmanuelle"},{"role":"aut","display":"Nicaise, Yvan","family":"Nicaise","given":"Yvan"},{"display":"Sievers, Philipp","role":"aut","family":"Sievers","given":"Philipp"},{"display":"Deimling, Andreas von","role":"aut","family":"Deimling","given":"Andreas von"},{"family":"Sahm","role":"aut","display":"Sahm, Felix","given":"Felix"},{"given":"Oumaima","role":"aut","display":"Aboubakr, Oumaima","family":"Aboubakr"},{"family":"Métais","display":"Métais, Alice","role":"aut","given":"Alice"},{"family":"Chrétien","display":"Chrétien, Fabrice","role":"aut","given":"Fabrice"},{"given":"Pascale","display":"Varlet, Pascale","role":"aut","family":"Varlet"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"24 October 2023"}],"name":{"displayForm":["Arnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, Philipp Sievers, Andreas von Deimling, Felix Sahm, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, Pascale Varlet"]},"title":[{"subtitle":"letter to the editor","title_sort":"Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status","title":"Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"id":{"issn":["2051-5960"],"eki":["746066465"],"zdb":["2715589-4"]},"part":{"text":"11(2023), Artikel-ID 170, Seite 1-4","year":"2023","volume":"11","pages":"1-4","extent":"4"},"origin":[{"dateIssuedKey":"2013","publisherPlace":"London","publisher":"Biomed Central","dateIssuedDisp":"2013-"}],"title":[{"title_sort":"Acta Neuropathologica Communications","title":"Acta Neuropathologica Communications"}],"disp":"Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status letter to the editorActa Neuropathologica Communications","pubHistory":["1.2013 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"746066465","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 29.11.18"]}],"physDesc":[{"extent":"4 S."}],"recId":"1882343549","language":["eng"],"note":["Gesehen am 01.03.2024"]} | ||
| SRT | |a TAUZIEDEESREFINEMENT2420 | ||